A carregar...

Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse.

Oral formulations of 5-aminosalicylic acid (mesalazine) appear less toxic than sulphasalazine. We have therefore compared sulphasalazine, low dose mesalazine and high dose mesalazine in the treatment of mild to moderate relapse of ulcerative colitis. Sixty one patients (32 men, aged 20-78 years) wer...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Riley, S A, Mani, V, Goodman, M J, Herd, M E, Dutt, S, Turnberg, L A
Formato: Artigo
Idioma:Inglês
Publicado em: 1988
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1433642/
https://ncbi.nlm.nih.gov/pubmed/2899536
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!